Psoriasis

SFA Therapeutics will begin a Phase 1b trial of patients suffering from Mild to moderate Psoriasis 3Q2020

The study will be conducted in conjunction with Temple University in Philadelphia, PA. Estimated start date is 1 October, 2020

For information contact us at info@sfatherapeutics.com

Images represent results of open label limited exposure

Images are taken after 30 days.

Images of patients taken after 30 days exposure

Data is open label limited exposure

Images of patients taken after 30 days exposure

Data is open label limited exposure